Andromeda Metals Limited

ADN

Andromeda Metals Ltd. operates as a mineral exploration company, which engages in the advancement of Great White Kaolin Project (GWKP) through the development of production facilities for halloysite-kaolin products. The company is headquartered in Adelaide, South Australia. The firm is engaged in the sustainable supply of industrial minerals and the advancement of nanotechnologies. The firm's Great White Project (GWP) contains several deposits containing a naturally occurring blend of halloysite tubes and kaolinite plates. The Great White Project is located within the District Council of Streaky Bay, near the community of Poochera on the Eyre Peninsula in South Australia. Its Mount Hope Kaolin Project is located 80 kilometers (km) northwest of Port Lincoln on the Eyre Peninsula in South Australia. The company contains some of the brightest, whitest kaolin in the world. Together with its portfolio of halloysite-kaolin projects, it is also developing several copper and gold prospects across Australia. Its Eyre Kaolin Project is composed of four exploration tenements totaling 2,799 square kilometers on the Western Eyre Peninsula, South Australia.

Fortescue Ltd

FMG

Fortescue Ltd. engages in the development of iron ore deposits. The company is headquartered in Perth, Western Australia. The firm's segments include Metals and Energy. Metals segment includes exploration, development, production, processing, sale and transportation of iron ore, and the exploration for other minerals. Its metals business comprises its iron ore operations in the Pilbara as well as a pipeline of exploration projects globally including in Gabon in Africa, Latin America and Australia. The firm's metals business includes Hedland operations, Chichester Hub, Western Hub, Iron Bridge, Green Metal Project, integrated operations, Belinga Project, Blacksmith Project and Pilbara Energy Connect (PEC) project. Energy segment undertakes activities in the global development of green electricity, green hydrogen, green ammonia projects, as well as green technology development and manufacturing. Its energy business includes Arizona Hydrogen project, Holmaneset project, Pecem project and Gladstone PEM50 Project.

Highfield Resources Limited

HFR

Highfield Resources Ltd. engages in the mineral exploration and development. The company is headquartered in Pamplona, Navarra and currently employs 25 full-time employees. The company went IPO on 2012-01-17. The firm has around four potash projects. The firm's Muga, Vipasca, Izaga, Pintanos and Sierra del Perdon potash projects are located in the Ebro potash producing basin in northern Spain covering a project area of over 550 square kilometers. The Muga project targets the shallow sylvinite beds to the south east of the project area. The Muga project is located approximately 50 kilometers to the southeast of Pamplona. The Sierra del Perdon project is located approximately 10 kilometers from Pamplona. The Vipasca project area includes the Vipasca permit, the Borneau permit and the Osquia permit. The Pintanos project covers an area of around 125 square kilometers abutting the Muga-Vipasca project. The Izaga project is located in a syncline structure abutting the northern extent of the expanded Vipasca project.

Mesoblast Limited

MSB

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-12-16. The company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. The company is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. The company has established commercial partnerships in Europe and China for certain Phase III assets.

Betashares Nasdaq 100 ETF

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.